These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. Sammarco G; Varricchi G; Ferraro V; Ammendola M; De Fazio M; Altomare DF; Luposella M; Maltese L; Currò G; Marone G; Ranieri G; Memeo R Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035644 [TBL] [Abstract][Full Text] [Related]
7. Tumor-Associated Mast Cells in Thyroid Cancer. Visciano C; Prevete N; Liotti F; Marone G Int J Endocrinol; 2015; 2015():705169. PubMed ID: 26379707 [TBL] [Abstract][Full Text] [Related]
8. Are Mast Cells MASTers in Cancer? Varricchi G; Galdiero MR; Loffredo S; Marone G; Iannone R; Marone G; Granata F Front Immunol; 2017; 8():424. PubMed ID: 28446910 [TBL] [Abstract][Full Text] [Related]
9. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy. Albini A; Bruno A; Noonan DM; Mortara L Front Immunol; 2018; 9():527. PubMed ID: 29675018 [TBL] [Abstract][Full Text] [Related]
10. Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis. Marone G; Varricchi G; Loffredo S; Granata F Eur J Pharmacol; 2016 May; 778():146-51. PubMed ID: 25941082 [TBL] [Abstract][Full Text] [Related]
11. Immune cells as a source and target of angiogenic and lymphangiogenic factors. Loffredo S; Staiano RI; Granata F; Genovese A; Marone G Chem Immunol Allergy; 2014; 99():15-36. PubMed ID: 24217601 [TBL] [Abstract][Full Text] [Related]
12. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Qu X; Tang Y; Hua S Front Immunol; 2018; 9():563. PubMed ID: 29662489 [TBL] [Abstract][Full Text] [Related]
13. Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? Rotondi M; Coperchini F; Latrofa F; Chiovato L Front Endocrinol (Lausanne); 2018; 9():314. PubMed ID: 29977225 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413 [TBL] [Abstract][Full Text] [Related]
15. Roles of neutrophils in cancer growth and progression. Galdiero MR; Varricchi G; Loffredo S; Mantovani A; Marone G J Leukoc Biol; 2018 Mar; 103(3):457-464. PubMed ID: 29345348 [TBL] [Abstract][Full Text] [Related]
16. Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by Hras Jolly LA; Massoll N; Franco AT J Clin Cell Immunol; 2016 Oct; 7(5):. PubMed ID: 27942419 [TBL] [Abstract][Full Text] [Related]
17. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis. Liu X; Li X; Wei H; Liu Y; Li N Front Immunol; 2023; 14():1209056. PubMed ID: 37497234 [TBL] [Abstract][Full Text] [Related]
18. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Stockmann C; Schadendorf D; Klose R; Helfrich I Front Oncol; 2014; 4():69. PubMed ID: 24782982 [TBL] [Abstract][Full Text] [Related]
19. [Angiogenesis and immune suppression: yin and yang of tumor progression?]. Szala S Postepy Hig Med Dosw (Online); 2009 Dec; 63():598-612. PubMed ID: 20009124 [TBL] [Abstract][Full Text] [Related]
20. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A Front Immunol; 2019; 10():757. PubMed ID: 31031757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]